Contact Information

Oak Avenue, Manhattan Beach, California 90266

Contact Us

REUTERS: Johnson & Johnson on Friday(Jan 29) claimed its single-dose injection was 72 percent efficient in stopping COVID-19 in the United States. A lower rate of 66 per cent effectiveness was observed in a bigger global test carried out across three continents and also against numerous stress of the virus.

In a trial involving nearly 44,000 volunteers, the level of protection against modest and also severe COVID-19 was 66 per cent in Latin America and simply 57 per cent in South Africa, where an especially distressing variation of the novel coronavirus is flowing.

New COVID-19 versions: Do the UK and South Africa infection pressures pose a risk to Singapore?

Those outcomes contrast to the high bar established by 2 authorised injections from Pfizer-BioNTech and Moderna, which were around 95 percent effective when given up 2 dosages.

Those tests, nevertheless, were carried out mainly in the US, before the wide spread of new variations currently under the spotlight.

Pfizer-BioNTech COVID-19 vaccination just a little less effective versus essential South African & mutations: Study Johnson & Johnson’s primary research study objective was the prevention of moderate to extreme COVID-19, and also the vaccination was 85 per cent effective in stopping extreme illness as well as stopping hospitalisation across all locations and versus numerous variations 28 days after immunisation.

Notify of
Inline Feedbacks
View all comments